The Effect of Adding Auditory Information on Head Movements in People With Traumatic Neck Pain

August 31, 2023 updated by: Steffan Wittrup Christensen, Aalborg University
This study sets out to investigate the potential effect of auditory disturbances on human movement

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Clinicians routinely investigate/test human movement but if/how this is effect by auditory disturbances is unclear. This study sets out to investigate the impact of auditory disturbances on head movements.

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Steffan WM Christensen, PhD
  • Phone Number: (+45) 99408889
  • Email: stc@hst.aau.dk

Study Locations

      • Aalborg, Denmark, 9000
        • FysioDanmark Aalborg
      • Gistrup, Denmark, 9260
        • Dept. Of Health Science and Technology, Aalborg University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Control group:

Inclusion Criteria (Control):

  • Able to speak, read and understand Danish/English

Exclusion Criteria (Control):

  • Pain from the neck or shoulder area during the past 6 months
  • Experience of delayed onset muscle soreness (DOMS) during the week leading up to the test session
  • Former surgery in neck or shoulder
  • Current or previous chronic or recurrent pain condition that could affect the results
  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Previous neurologic, musculoskeletal or mental illnesses that could affect the results
  • Regular use of analgesics
  • Abnormally disrupted sleep in the last 24 hours preceding the experiment
  • Lack of ability to cooperate

Neck pain group:

Inclusion Criteria (Neck Pain):

  • Traumatic onset of neck pain
  • Able to speak, read and understand Danish/English
  • Reduced/painful active range of motion of the head and/or painful reaction to palpation of the neck at the time of inclusion

Exclusion Criteria (Neck Pain):

  • Experience of DOMS during the week leading up to the test session
  • Former surgery in neck or shoulder
  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Previous neurologic, musculoskeletal (other than neck pain) or mental illnesses that could affect the results
  • Abnormally disrupted sleep in the 24 hours preceding the experiment
  • Lack of ability to cooperate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sound 1
A sound will be played while moving the head
A sound will be played from a portable device (smartphone mounted with earphones) during movement
Experimental: Sound 2
A sound (different from Sound 1) will be played while moving the head
A sound will be played from a portable device (smartphone mounted with earphones) during movement
No Intervention: No Sound
No sound will be played while moving the head

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: During a single test session (approximately 45minutes) at day 1
Range of motion will be assessed during head rotations (i.e. moving the head from a neutral position to end of range in rotation before returning to the start position)
During a single test session (approximately 45minutes) at day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Head repositioning accuracy
Time Frame: During a single test session (approximately 45minutes) at day 1
Head repositioning accuracy will be assessed as the error between the starting point and the end point following a head rotation (i.e. moving the head from a neutral position to end of range in rotation before returning to the start position) and will be repressed in degrees.
During a single test session (approximately 45minutes) at day 1
Quality of head movement
Time Frame: During a single test session (approximately 45minutes) at day 1
Quality of movement (smoothness) will be determined using calculations of jerk variance (Jerk is the time derivative of acceleration which will be measures using an inertial measurement unit. The measure will be converted to a unitless measure where higher values indicates less smooth movements), assessed during head rotations (i.e. moving the head from a neutral position to end of range in rotation before returning to the start position).
During a single test session (approximately 45minutes) at day 1
Perceived stiffness during movement
Time Frame: During a single test session (approximately 45minutes) at day 1
Participants will rate their perceived stiffness during head movement using a 0-100 numerical rating scale, where 0 = no stiffness and 100 = worst stiffness imaginable.
During a single test session (approximately 45minutes) at day 1
Perceived difficultness of performing movement
Time Frame: During a single test session (approximately 45minutes) at day 1
Participants will rate the Perceived difficultness of performing head movements using a 6-point Likert scale going from 0 = no problems, 1 = minimally difficult; 2 = somewhat difficult; 3 = fairly difficult; 4 = very difficult; 5 = unable to perform
During a single test session (approximately 45minutes) at day 1
Perceived neck pain intensity
Time Frame: During a single test session (approximately 45minutes) at day 1
Participants will rate ant potential pain during the session using a 0-11 numeric rating scale (NRS) with 0 = no pain and 10 = worst imaginable pain
During a single test session (approximately 45minutes) at day 1

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck Disability Index (NDI)
Time Frame: At the beginning of the single test session (approximately 45minutes) at day 1
The NDI questionnaire consists of 10 items (Domains: pain intensity, personal care, lifting, reading, headache, concentration, work, driving, sleeping, recreation) used to assess how neck pain affects your ability to manage everyday activities. Each item is score on a scale from 0-5 with a higher total score = high level of disability
At the beginning of the single test session (approximately 45minutes) at day 1
Tampa Scale for Kinesiophobia (TSK-11)
Time Frame: At the beginning of the single test session (approximately 45minutes) at day 1
The TSK-11 questionnaire consists of 11 items which is answered using a 4-point scale (1 = strongly disagree, 2 = disagree, 3 = agree, 4 = strongly agree). Score can range from 11 to 44 and a higher score indicated a greater kinesiophobia
At the beginning of the single test session (approximately 45minutes) at day 1
Perceived area of neck pain
Time Frame: At the beginning of the single test session (approximately 45minutes) at day 1
Participants will draw the area of perceived neck pain on a body chart
At the beginning of the single test session (approximately 45minutes) at day 1
Fear Avoidance Beliefs Questionnaire-physical activity subscale (FABQpa)
Time Frame: Time Frame: At the beginning of the single test session (approximately 45minutes) at day 1
The FABQpa subscale consists of 4 items which are used to assess the participants beliefs on how physical activity can affect their pain. The items are scored on a 7-point scale with 0 = Completely disagree and 6 = Completely agree. Score ranges from 0-24 with a higher score indicating higher fear avoidance beliefs with regards to physical activity
Time Frame: At the beginning of the single test session (approximately 45minutes) at day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Steffan WM Christensen, PhD, Aalborg University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 31, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

August 22, 2023

First Submitted That Met QC Criteria

August 31, 2023

First Posted (Actual)

September 8, 2023

Study Record Updates

Last Update Posted (Actual)

September 8, 2023

Last Update Submitted That Met QC Criteria

August 31, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • AAU031-1025976b

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Smartphone playing a sound

Subscribe